Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City.

Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City.
复制标题

DOI:
10.1080/10826084.2021.1892142
复制
发表时间:
2021
影响因子:
2
通讯作者:
Walters SM
Walters SM
中科院分区:
医学4区
文献类型:
--
作者:
Muncan B;Jordan AE;Perlman DC;Frank D;Ompad DC;Walters SM

文献摘要

参考文献

被引文献

相似文献

丙型肝炎(HCV)感染在注射吸毒者(PWID)中的发病率正在上升。即使在已知的HCV预防和治疗策略的背景下,一些PWID仍然没有参与HCV治疗。本研究旨在确定和描述PWID在当地注射器服务计划(SSP)中对HCV检测和治疗的可接受性和有效性的经验和看法。共有36名PWID参加了纽约市SSP的半结构化访谈。访谈由三名编码员录音、转录和编码,遵循建构主义扎根理论方法。相关主题是根据数据确定的。与PWID的访谈揭示了与SSP对HCV治疗影响相关的三个主题:(1)非污名化的SSP环境,(2)SSP在提高HCV知识方面的作用,以及(3)SSP作为PWID HCV治疗场所的可接受性。这篇论文有助于理解ssp为PWID提供了一个广泛接受的HCV服务来源。参与者认为,ssp是HCV治疗的可及和有效的场所,并建议PWID的耻辱感继续影响传统环境中HCV治疗的接受。了解PWID对ssp作为HCV治疗场所的有效性的态度和信念,对于制定减少HCV传播的重点战略并最终实现消除HCV至关重要。鉴于此,有必要进一步研究如何最好地改善诸如ssp等危害减少地点的HCV护理。
The incidence of hepatitis C (HCV) infection is rising among people who inject drugs (PWID). Even in the context of known HCV prevention and treatment strategies, some PWID remain unengaged in HCV care. This study aimed to identify and characterize experiences and perceptions of PWID regarding the acceptability and effectiveness of HCV testing and treatment at a local syringe service program (SSP). A total of 36 PWID participated in semi-structured interviews at an SSP in New York City. Interviews were audio-recorded, transcribed, and coded by three coders, following a constructivist grounded theory approach. Relevant themes were identified as they emerged from the data. Interviews with PWID revealed three themes related to the impact of SSPs on HCV care: (1) non-stigmatizing SSP environments, (2) the role of SSPs in improving HCV knowledge, and (3) acceptability of SSPs as sites for HCV care among PWID. This paper contributes to the ongoing understanding that SSPs provide a well-accepted source of HCV services for PWID. Participants believed that SSPs are accessible and effective sites for HCV care, and suggested that stigma among PWID continues to affect receipt of HCV care in traditional settings. Understanding attitudes and beliefs of PWID regarding the effectiveness of SSPs as sites for HCV care is crucial for the development of focused strategies to reduce HCV transmission, and to ultimately achieve HCV elimination. Given this, further research is warranted investigating how best to improve HCV care at harm reduction sites such as SSPs.
DOI: 10.1016/j.jsat.2016.01.009
发表时间: 2016-07-01
影响因子: 3.9
作者:
Carey, Katelyn J.;Huang, Wei;Tsui, Judith I.
通讯作者: Tsui, Judith I.
DOI: 10.1016/j.idc.2018.02.009
发表时间: 2018-06-01
影响因子: 4.4
作者:
Gaudino, Annette;Gay, Bryn;Graham, Camilla S.
通讯作者: Graham, Camilla S.
DOI: 10.1016/j.jsat.2016.12.014
发表时间: 2017-04-01
影响因子: 3.9
作者:
Butner, Jenna L.;Gupta, Neil;Tetrault, Jeanette M.
通讯作者: Tetrault, Jeanette M.
DOI: 10.1080/10826084.2020.1793367
发表时间: 2020-07-20
影响因子: 2
作者:
Cano, Manuel
通讯作者: Cano, Manuel
DOI: 10.1016/j.drugalcdep.2019.01.037
发表时间: 2019-05-01
影响因子: 4.2
作者:
Biancarelli, Dea L.;Biello, Katie B.;Bazzi, Angela R.
通讯作者: Bazzi, Angela R.